Applied Pharmaceutical Innovation (API) competitors & alternatives

PCI Pharma ServicesPharmaceuticalsUnited Kingdom

69% match

Pharmaceuticals

PCI Pharma Services is a global contract development and manufacturing organization (CDMO) that supports biopharmaceutical clients in bringing drug products to market.

Quotient LtdPharmaceuticalsUnited Kingdom

64% matchPrivate

Pharmaceuticals

Quotient Ltd, operating as Quotient Sciences, is a United Kingdom-based drug development and manufacturing accelerator that provides integrated programs and services across the development pathway.

SINOTHERAPEUTICS INC.688247 · PharmaceuticalsChina

64% matchPublic

Pharmaceuticals

Sinotherapeutics Inc. is a high-tech pharmaceutical enterprise focused on the research, commercial production, and sales of advanced drug formulations, including anti-infective, anti-tumor, metabolic, and cardiovascular medications. The company also provides innovative drug formulation CRO and CMO services to global patients and pharmaceutical partners.

MEDTIDE03880 · PharmaceuticalsHangzhou, China

63% matchPublic

Pharmaceuticals

Medtide Inc. operates as a contract research, development, and manufacturing organization (CRDMO), providing comprehensive services across the entire pharmaceutical lifecycle, from initial drug discovery and preclinical investigation through to clinical development and commercial-scale production. The company specializes in the synthesis of novel peptide chemical entities for discovery purposes, along with the development of peptide-based chemistry, manufacturing, and control (CMC) processes, and their subsequent commercial manufacturing. A core area of its developmental focus is on glucagon-like peptide-1 (GLP-1) molecules, which it designs for both oral and/or injectable administration. Medtide leverages a suite of proprietary research and development platforms, including OmniPeptSynth, PeptiConjuX, PeptiNuclide LinkTech, GreenSynth Innovations, and Impurity Screening. Its client base spans multiple regions globally, including China, the United States, Japan, Europe, South Korea, and Australia. Established in 2020 as Taide Pharmaceutical (Zhejiang) Co., Ltd, the company rebranded to Medtide Inc. in February 2023 and maintains its headquarters in Hangzhou, China.

Sai Life SciencesSAILIFE · BiotechIndia

68% matchPublic

Biotech

Sai Life Sciences operates as a Contract Research, Development, and Manufacturing Organization (CRDMO) providing services from drug discovery to manufacturing. It serves pharmaceutical and biotech companies by offering capabilities in synthetic medicinal chemistry, biology, drug metabolism and pharmacokinetics, process development, and drug substance manufacturing.

Aragen Life SciencesLife SciencesIndia

65% match

Life Sciences

Aragen Life Sciences Ltd. is a pharmaceutical manufacturing and contract research and development organization (CRDMO) headquartered in Hyderabad, India.

Anthem Biosciences LimitedANTHEM · BiotechBengaluru, India

65% matchPublic

Biotech

Anthem Biosciences Ltd. operates as a technology-driven organization specializing in contract research, development, and manufacturing (CRDMO). The company's activities are organized into two primary divisions: CRDMO services and the production of Specialty Ingredients. Through its CRDMO segment, Anthem Biosciences offers comprehensive, full-lifecycle support for both novel chemical and biological entities. This support spans the entire development pipeline, from initial target identification and concept generation, through preclinical evaluation, the creation of development batches for all three phases of clinical trials, and ultimately, commercial-scale manufacturing. Their expertise covers a wide array of advanced therapeutic areas, including RNA-based therapies, antibody-drug conjugates, peptides, oligonucleotides, lipids, biologics, and biotherapeutics. They also employ specialized processes such as fermentation, biosynthesis, biotransformation, and flow chemistry. In its Specialty Ingredients division, Anthem Biosciences manufactures and supplies intricate, fermentation-derived active pharmaceutical ingredients (APIs), including serratiopeptidase protease and vitamin K2. The company's portfolio also encompasses microbial and mammalian biosimilars, a diverse range of probiotics (such as various species of bacillus, lactobacillus, bifidobacterium, streptococcus, and saccharomyces boulardii), and enzymes. Additionally, they produce key peptides like semaglutide, plecanatide, linaclotide, liraglutide, and cilengitide, alongside nutritional actives, vitamin analogues, and other APIs. The company was established in Bengaluru, India, in 2006.

Almac GroupBiotechUnited Kingdom

64% match

Biotech

Almac Group is a global company that provides a range of services across the drug development lifecycle. They offer tailored solutions to support the pharmaceutical and biotechnology industries in advancing human health.

Syngene InternationalSYNGENE · BiotechIndia

64% matchPublic

Biotech

Syngene International is a contract research, development, and manufacturing organization (CRDMO) that provides integrated discovery, development, and manufacturing services for small molecules, biologics, and other therapeutic modalities. It serves clients in the pharmaceutical, biotechnology, nutrition, animal health, and agrochemical industries by supporting their research and commercial production needs.

Biotechnology

Shanghai OBiO Technology (Group) Corp., Ltd. is a biotechnology contract development and manufacturing organization (CDMO/CRO) focused on gene and cell therapy services, including viral-vector development and manufacturing. It serves pharmaceutical and biotechnology companies, academic institutions, and research organizations developing gene-therapy and related biologics products.

Kincell BioBiotechUnited States

63% match

Biotech

Kincell Bio operates as a cell therapy contract development and manufacturing organization (CDMO) that serves biopharmaceutical clients. The company provides GMP manufacturing, process and analytical development, chemistry, manufacturing, and controls (CMC) strategy, and characterization and release testing to support cell therapy programs from early development through commercial launch.

SHANGHAI OPM BIOSCIENCES CO., LTD.688293 · BiotechnologyChina

63% matchPublic

Biotechnology

Shanghai OPM Biosciences Co., Ltd. provides high-performance cell culture media, custom media development, and end-to-end CRDMO and CRO services for biopharmaceutical and biologics companies. Its offerings support clients across the drug R&D lifecycle, from early discovery and cell line development through clinical and commercial manufacturing.